vs
MIDDLEBY Corp（MIDD）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
MIDDLEBY Corp的季度营收约是Royalty Pharma plc的1.4倍（$866.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.3%，领先30.2%），Royalty Pharma plc同比增速更快（4.8% vs -30.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -3.3%）
美国Middleby公司是总部位于伊利诺伊州埃尔金的上市企业，主营商用烹饪设备、工业加工设备及民用家电，其商用烹饪设备业务覆盖美国及全球前100家餐饮连锁品牌中的97家，是全球餐饮设备领域的领先供应商。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MIDD vs RPRX — 直观对比
营收规模更大
MIDD
是对方的1.4倍
$622.0M
营收增速更快
RPRX
高出35.3%
-30.6%
净利率更高
RPRX
高出30.2%
4.3%
两年增速更快
RPRX
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $866.4M | $622.0M |
| 净利润 | $36.9M | $214.2M |
| 毛利率 | 38.8% | — |
| 营业利润率 | 17.3% | 62.4% |
| 净利率 | 4.3% | 34.4% |
| 营收同比 | -30.6% | 4.8% |
| 净利润同比 | -67.1% | 2.9% |
| 每股收益（稀释后） | $0.74 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MIDDRPRX
| Q4 25 | $866.4M | $622.0M | ||
| Q3 25 | $982.1M | $609.3M | ||
| Q2 25 | $977.9M | $578.7M | ||
| Q1 25 | $906.6M | $568.2M | ||
| Q4 24 | $1.0B | $593.6M | ||
| Q3 24 | $942.8M | $564.7M | ||
| Q2 24 | $991.5M | $537.3M | ||
| Q1 24 | $926.9M | $568.0M |
净利润MIDDRPRX
| Q4 25 | $36.9M | $214.2M | ||
| Q3 25 | $-513.0M | $288.2M | ||
| Q2 25 | $106.0M | $30.2M | ||
| Q1 25 | $92.4M | $238.3M | ||
| Q4 24 | $112.3M | $208.2M | ||
| Q3 24 | $114.2M | $544.0M | ||
| Q2 24 | $115.4M | $102.0M | ||
| Q1 24 | $86.6M | $4.8M |
毛利率MIDDRPRX
| Q4 25 | 38.8% | — | ||
| Q3 25 | 36.8% | — | ||
| Q2 25 | 38.0% | — | ||
| Q1 25 | 38.2% | — | ||
| Q4 24 | 38.4% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 38.3% | — | ||
| Q1 24 | 37.4% | — |
营业利润率MIDDRPRX
| Q4 25 | 17.3% | 62.4% | ||
| Q3 25 | -56.4% | 70.1% | ||
| Q2 25 | 15.9% | 36.3% | ||
| Q1 25 | 15.5% | 94.0% | ||
| Q4 24 | 16.8% | 60.9% | ||
| Q3 24 | 18.4% | — | ||
| Q2 24 | 17.7% | 50.2% | ||
| Q1 24 | 14.8% | -13.0% |
净利率MIDDRPRX
| Q4 25 | 4.3% | 34.4% | ||
| Q3 25 | -52.2% | 47.3% | ||
| Q2 25 | 10.8% | 5.2% | ||
| Q1 25 | 10.2% | 41.9% | ||
| Q4 24 | 11.1% | 35.1% | ||
| Q3 24 | 12.1% | 96.3% | ||
| Q2 24 | 11.6% | 19.0% | ||
| Q1 24 | 9.3% | 0.8% |
每股收益（稀释后）MIDDRPRX
| Q4 25 | $0.74 | $0.49 | ||
| Q3 25 | $-10.15 | $0.67 | ||
| Q2 25 | $1.99 | $0.07 | ||
| Q1 25 | $1.69 | $0.55 | ||
| Q4 24 | $2.07 | $0.46 | ||
| Q3 24 | $2.11 | $1.21 | ||
| Q2 24 | $2.13 | $0.23 | ||
| Q1 24 | $1.59 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.2M | $618.7M |
| 总债务越低越好 | $2.2B | $9.0B |
| 股东权益账面价值 | $2.8B | $9.7B |
| 总资产 | $6.3B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.78× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MIDDRPRX
| Q4 25 | $222.2M | $618.7M | ||
| Q3 25 | $175.1M | $938.9M | ||
| Q2 25 | $511.5M | $631.9M | ||
| Q1 25 | $745.1M | $1.1B | ||
| Q4 24 | $689.5M | $929.0M | ||
| Q3 24 | $606.0M | $950.1M | ||
| Q2 24 | $459.5M | $1.8B | ||
| Q1 24 | $341.0M | $843.0M |
总债务MIDDRPRX
| Q4 25 | $2.2B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $2.4B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MIDDRPRX
| Q4 25 | $2.8B | $9.7B | ||
| Q3 25 | $2.9B | $9.6B | ||
| Q2 25 | $3.6B | $9.5B | ||
| Q1 25 | $3.7B | $9.8B | ||
| Q4 24 | $3.6B | $10.3B | ||
| Q3 24 | $3.6B | $10.3B | ||
| Q2 24 | $3.4B | $9.8B | ||
| Q1 24 | $3.3B | $9.9B |
总资产MIDDRPRX
| Q4 25 | $6.3B | $19.6B | ||
| Q3 25 | $6.4B | $19.3B | ||
| Q2 25 | $7.3B | $18.3B | ||
| Q1 25 | $7.4B | $17.6B | ||
| Q4 24 | $7.3B | $18.2B | ||
| Q3 24 | $7.2B | $18.0B | ||
| Q2 24 | $7.0B | $17.7B | ||
| Q1 24 | $6.9B | $16.1B |
负债/权益比MIDDRPRX
| Q4 25 | 0.78× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.66× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $165.5M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 1.5% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $530.1M | — |
8季度趋势，按日历期对齐
经营现金流MIDDRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $176.3M | $702.6M | ||
| Q2 25 | $122.0M | $364.0M | ||
| Q1 25 | $141.1M | $596.1M | ||
| Q4 24 | $239.7M | $742.5M | ||
| Q3 24 | $156.7M | $703.6M | ||
| Q2 24 | $149.5M | $658.2M | ||
| Q1 24 | $140.9M | $664.6M |
自由现金流MIDDRPRX
| Q4 25 | $165.5M | — | ||
| Q3 25 | $156.1M | — | ||
| Q2 25 | $101.1M | — | ||
| Q1 25 | $107.4M | — | ||
| Q4 24 | $226.6M | — | ||
| Q3 24 | $145.2M | — | ||
| Q2 24 | $138.6M | — | ||
| Q1 24 | $127.2M | — |
自由现金流率MIDDRPRX
| Q4 25 | 19.1% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 22.3% | — | ||
| Q3 24 | 15.4% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 13.7% | — |
资本支出强度MIDDRPRX
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.5% | — |
现金转化率MIDDRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 1.15× | 12.06× | ||
| Q1 25 | 1.53× | 2.50× | ||
| Q4 24 | 2.13× | 3.57× | ||
| Q3 24 | 1.37× | 1.29× | ||
| Q2 24 | 1.30× | 6.45× | ||
| Q1 24 | 1.63× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIDD
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
